A research filter, not a predictor — not financial advice. Grades rank growth stocks on evidence-based quality signals from end-of-day data; they are not buy/sell calls or price forecasts. Always do your own research.

Lifecore Biomedical, Inc. LFCR

Weak broader-coverage candidate · Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States,

On FrontierLab's discovery record since 2026-09-28 (8 days ago) — when this name first surfaced. (distinct from the snapshot date below)

Auto-graded broader coverage — sourced by an automated screen and graded on default bands, not the sector-calibrated bands the curated screener uses. A "Weak" here is NOT the same bar as a curated grade; these are auto-screened candidates for your own research, shown as of their surface date (2026-09-29), not the curated Frontier signal.

⚡ Surfaced on a price move — momentum is where to look, not a buy signal. The move that surfaced this name does not make it a good entry.

⚠ Pump risk: parabolic/spike characteristics detected in the screen flags. Treat any positive grade with extra skepticism.

Key quality signals

Revenue growth (YoY)	-4.8%
Gross margin	29.7%
Gross profits / assets	0.16
Rule of 40	-6.9
Net margin	-2.1%
Cash runway (months)	—
PEG	—
Price / sales	2

Quality checklist

✗ Revenue growth — -4.8% (pass ≥ 20%)
✗ Gross profits / assets — 0.16 (pass ≥ 0.33)
✗ Gross margin — 29.7% (pass ≥ 60%)
✓ Cash generation
✗ Share dilution — 9.4%

Fundamentals — snapshot as of 2026-09-29

Stage	Established
Share issuance (YoY)	9.4% · heavy issuance
Moat	—
TAM	—
P/E (trailing)	—
EPS (trailing)	$-1.10
Burn multiple	—
Gross-margin trend (pts)	-1.6
Cash / assets	0.08
Net debt / EBITDA	—
Statements as of	Q2 FY2026 · filed 2026-08-05

Momentum context — a snapshot from 2026-09-29, not current

Price at surface	$6.52 (as of 2026-09-29)
52-week range	$3.63 – $8.98
% off 52-wk high	-27.4%
RSI (14)	79
Relative volume	11.5×

Risk flags

Burning cash — operating margin is negative.Thin gross margin — keeps little of each sales dollar (judge it against its industry).Heavy share dilution (>5%/yr) — your slice shrinks.Parabolic one-day spike (+55%) in the last month — extreme single-day moves tend to mean-revert.Volume 11.5× normal alongside the move — attention-crowded names tend to reverse over the following weeks.

← All broader-coverage names · Curated names → · Open the interactive screener →

Data as of 2026-09-29 (end-of-day). How grades are computed →